Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SmithKline Beecham to modify Nicoderm CQ comparative TV ad following NARB decision.

This article was originally published in The Tan Sheet

Executive Summary

SMITHKLINE NICODERM CQ COMPARATIVE TV AD MODIFIED prior to an Oct. 10 decision by the National Advertising Review Board, the company said. The NARB decision settles SmithKline Beecham's appeal of a June 12 opinion by the National Advertising Division of the Council of Better Business Bureaus that recommended specifically how a Nicoderm CQ television ad should be changed to portray more accurately the differing nicotine content and treatment time for the transdermal patch and its competitor, McNeil Consumer Product's Nicotrol ("The Tan Sheet" June 16, p. 8). NARB upheld NAD's position but allowed SmithKline to decide exactly how it will alter the ad.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087684

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel